Pancreatic Cancer Research

ResearcherNanjing Medical UniversityNo recent work listed

Dong-liu Miao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8564-1012; OpenAlex author ID A5059501576. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers

Papers 4

  1. Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-022-07112-8↗
  2. Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fgene.2022.941389↗
  3. Integrated analysis of circular RNA-associated ceRNA network in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ol.2020.11306↗
  4. Nomogram for predicting survival in patients with pancreatic cancer. First author DOI 10.2147/ott.s154599↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhi-gang Zhu · 2 shared papers, 2022 · strength 0.40
  2. Wei Song · 2 shared papers, 2018–2020 · strength 0.28
  3. Qiong Wu · 1 shared paper, 2022 · strength 0.20
  4. Qiong Wu · 1 shared paper, 2022 · strength 0.20
  5. Lei Chen · 1 shared paper, 2018 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.